Product Categories
| Country: | China |
|---|---|
| Tel: | 0755-66853366 |
| Mobile: | 13670046396 |
| E-mail: | orders@qcsrm.com |
| QQ: | 2851296956 |
| Skype: | Chat Now! |
| Address: | B1-203 & B3-402 Life Science Park SCT Creative Factory, Pingshan District ShenZhen, China |
| Product Name | MF | CAS | Details |
|---|
| 2-amino-3-chloropropanoic acid | C3H6ClNO2 | Details |
| 1,1-diphenylurea | C13H12N2O | Details |
| 2-chloro-N-methylethan-1-amine | Details |
| phenyl dihydrogen phosphite | Details |
| 5-bromo-4-(3-chlorothiophen-2-yl)thiazol-2-amine | Details |
| 5-bromo-4-(4,5-dichlorothiophen-2-yl)thiazol-2-amine | Details |
| 5-bromo-4-(5-chlorothiophen-2-yl)thiazol-2-amine | Details |
| 4,7-dichloroindoline-2,3-dione | C8H3Cl2NO2 | Details |
| 1-(4-cyclopropylphenyl)ethan-1-one | C11H12O | Details |
| 4,7-dichloro-3-hydroxy-3-(2-oxo-2-phenylethyl)indolin-2-one | Details |
| 4-chloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one | Details |
| 4,7-dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one | C19H15Cl2NO3 | Details |
| (Z)-4,7-dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethylidene)indolin-2-one | Details |
| 2-(4-benzyl-1,4-diazepan-1-yl)acetic acid | C14H20N2O2 | Details |
| 2-(benzo[d][1,3]dioxol-5-yl)acetamide | Details |
| 2-(benzo[d][1,3]dioxol-5-yl)-N-(2-(benzo[d][1,3]dioxol-5-yl)acetyl)acetamide | Details |
| 1-(phenylcarbamothioyl)pyrrolidine-2-carboxamide | Details |
| (S)-1-(palmitoyloxy)-3-(phosphonooxy)propan-2-yl heptadecanoate | Details |
| bicyclo[1.1.0]butane-2-carboxylic acid | C5H6O2 | Details |
| 4-(bromosulfonyl)butane-1-sulfonic acid | Details |
| dibutyl butane-1,4-disulfonate | Details |
| 4-(ethoxysulfonyl)butane-1-sulfonic acid | Details |
| 4-(butoxysulfonyl)butane-1-sulfonic acid | Details |
| 1-butyl 4-ethyl butane-1,4-disulfonate | Details |
| 1,1'-(4-butoxy-1,3-phenylene)diethanone | Details |
| Acrylic acid cyclodextrin derivatives | Details |
| Calcitonin (Salmon) EP Impurity A | Details |
| 5-chloro-N-(4-iodophenyl)pentanamide | C11H13ClINO | Details |
| (2-(chloromethoxy)ethoxy)methanol | Details |
| 2-chloroacetic 2-hydroxyacetic anhydride | Details |
| 2-chloro-5-(4-cyclohexylpiperazin-1-yl)-4-(4,5-dichlorothiophen-2-yl)thiazole | Details |
| 2-(3-chlorophenyl)butanoyl chloride | Details |
| Citric acid Impurity 2 | Details |
| Citric acid Impurity 3 | Details |
| Citric acid Impurity 4 | Details |
| N-cyclopropylnitrous amide | Details |
| N-(2-chloro-4-hydroxyphenyl)nitrous amide | Details |
| Ethylene Dicysteine Diethyl Ester (ECD) | Details |
| Dextran Impurity 1 | Details |
| 3H-diazirin-3-yl propionate | Details |
| 2,4-dichlorobenzene-1,3,5-triol | C6H4Cl2O3 | Details |
| 1-(3-(dimethylamino)propyl)-3-ethyl-1-nitrosourea | Details |
| 3-(3-(dimethylamino)propyl)-1-ethyl-1-nitrosourea | Details |
| 1-(3-(dimethylamino)propyl)-3-ethyl-1,3-dinitrosourea | Details |
| 6-(4-(diethylamino)-3-nitrophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one | Details |
| diethyl 2-(2-bromobut-3-en-1-yl)malonate | Details |
| (S)-4-(difluoromethyl)thiazolidin-2-one | Details |
| 7-oxo-7,10-dihydroimidazo[4,5,1-ij]pyrrolo[2,3-f]quinoline-1,3,9-tricarboxylic acid | Details |
| 2-amino-4-chlorobenzene-1,3,5-trisulfonamide | Details |
| Dopaquinone Impurity 2 | Details |
| 3,5-Di-tert-butyl-4-hydroxyphenylpropionic Acid | C17H26O3 | Details |
| ethyl 3-oxocyclohexa-1,4-dienecarboxylate | Details |
| (6Z,9Z,12Z)-ethyl hexadeca-6,9,12-trienoate | Details |
| ethyl 3-aminobenzenesulfonate | C8H11NO3S | Details |
| N,N'-(4-ethoxy-1,3-phenylene)diacetamide | Details |
| N'-butylformohydrazide | Details |
| hex-3-ene-1,1,6,6-tetracarboxamide | Details |
| 2-(2-hydroxyethoxy)ethyl trifluoromethanesulfonate | Details |
| 3-hydroxyoxetane-2-carboxylic acid | Details |
| Propane-1,2,3-triyl-d5 trinitrate | Details |
| 4-(hydroxy(nitroso)amino)-4-oxobutanoic acid | Details |
| 1-(2,4-bis(2-hydroxypropan-2-yl)phenyl)ethanone | Details |
| 1-(2,5-bis(2-hydroxypropan-2-yl)phenyl)ethanone | Details |
| 1,2-Dioctanoylglycerol | C19H36O5 | Details |
| Indole-3-carboxaldehyde-13C8 | C13C8H7NO | Details |
| isopropyl 4-aminobenzenesulfonate | Details |
| Lactic acid tetramer | Details |
| (R,Z)-2-ammonioethyl (3-((16-carboxyhexadec-8-enoyl)oxy)-2-hydroxypropyl) phosphate | C22H42NO9P | Details |
| Lithospermic acid Impurity 2 | Details |
| Memantine-Galactose Adduct 1 | Details |
| (4-methoxy-4-oxobut-2-en-2-yl)-D-valine | Details |
| 3-methyloxetane-2-carboxylic acid | C5H8O3 | Details |
| 2-(4-methylpyrimidin-2-yl)cyclopropane-1-carboxylic acid | Details |
| 2-(4-(2-((4-mercaptobenzoyl)oxy)ethyl)piperazin-1-yl)ethanesulfonic acid | Details |
| 2-(4-(2-((3-mercaptopropanoyl)oxy)ethyl)piperazin-1-yl)ethanesulfonic acid | Details |
| methyl 2-amino-2-phenylacetate | C9H11NO2 | Details |
| methyl 3-aminobenzenesulfonate | Details |
| methyl 5-chloro-4-methylpentanoate | C7H13ClO2 | Details |
| ethyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17,19-pentaenoate | Details |
| ethyl (5E,8E,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate | Details |
| ethyl (5Z,8E,11E,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate | Details |
| ethyl (5Z,8E,11Z,14E,17Z)-icosa-5,8,11,14,17-pentaenoate | Details |
| ethyl (5E,8E,11E,14Z,17E)-icosa-5,8,11,14,17-pentaenoate | Details |
| ethyl (4Z,7Z,10Z,13Z,16Z)-icosa-4,7,10,13,16,19-hexaenoate | Details |
| ethyl (6Z,9Z,12Z,15Z)-nonadeca-6,9,12,15,18-pentaenoate | Details |
| ethyl (5Z,8Z,11Z,14Z)-nonadeca-5,8,11,14-tetraenoate | Details |
| ethyl (7Z,10Z,13Z,16Z)-icosa-7,10,13,16,19-pentaenoate | Details |
| ethyl (5Z,8Z,11E,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate | Details |
| ethyl 2-((tert-butoxycarbonyl)(cyclopropylmethoxy)amino)benzoate | Details |
| tert-butyl cyclobutoxycarbamate | Details |
| Ethyl 2-((tert-butoxycarbonyl)(cyclobutoxy)amino)benzoate | Details |
| Perfluoro-1 -octane | Details |
| PD-1/PD-L1 inhibitor Impurity 1 | Details |
| PD-1/PD-L1 inhibitor Impurity 2 | Details |
| PD-1/PD-L1 inhibitor Impurity 3 | Details |
| PD-1/PD-L1 inhibitor Impurity 4 | Details |
| PD-1/PD-L1 inhibitor Impurity 5 | Details |
| PD-1/PD-L1 inhibitor Impurity 6 | Details |
| PD-1/PD-L1 inhibitor Impurity 7 | Details |
| Trelagliptin Impurity 24 | Details |
| Product Total： Product Page： | ||||
| 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 | ||||